SUSCEPTIBILITY TEST OF DERMATOPHYTES FUNGI AGAINST BIOGENIC SILVER NANOPARTICLES, FLUCONAZOLE AND SIMVASTATIN

Vol 2, 2018 - 95077
APRESENTAÇÃO DE PAINEL
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Dermatophyte fungi are those that aflict keratinized tissues, as skin, hair and nails. Many people and animals have or had been in contact with this kind of fungi. To the treatment, antifungals as Clotrimazole, Itraconazole and Miconazole are administered. With the high frequency plus the indiscriminate use of the antifungals, the microorganisms yield resistance mechanisms against the drugs. Diversely, some of the compounds used for treatment of the high levels of cholesterol, as Simvastatin, acts in the Ergosterol pathway, an important sterol present in the fungi membrane. Materials at nanoscale have gained its importance in the last decades and the use of the Silver Nanoparticles (AgNP) has been highlighted as a good antimicrobial among them. Its diversified action mechanism, size and shape allow the growth control of both bacteria and fungus. The aim of this work is to test the activity of the biogenic AgNP, produced by Fusarium oxysporum in our lab, Simvastatin and Fluconazole, as a group control, against two isolates of dermatophytes fungi, Trichophyton mentagrophytes and T. rubrum. The drugs were tested by the broth microdilution test (CLSI M38-A) to obtain the minimum inhibitory concentration (MIC). Both fungi were cultivated in Potato Dextrose Agar by 14 days at 30ºC, the spores were suspended in PBS and the suspension was adjusted to 104.ml-1. T. mentagrophytes was inhibited with 4,20 µg.ml-1, over 31,25 µg.ml-1 and 156,25 µg.ml-1 of AgNP, Fluconazole and Simvastatin, respectively. T. rubrum had its growth unseen at the 3,37 µg.ml-1, over 31,25 µg.ml-1 and 156,25 µg.ml-1 of AgNP, Fluconazole and Simvastatin, respectively. These results show us an excellent activity of the Silver Nanoparticle, which is the main compound of our study, presenting a high growth control of the fungi tested with a very low concentration. At both fungi, Fluconazole presented concentrations higher than 31,25 µg.ml-1, sometimes reaching 62,5 µg.ml-1 and 125 µg.ml-1. This makes the latter a unuseful drug regarding the treatment of T. mentagrophytes and T. rubrum dermatophytosis. Was observed that both fungi showed resistance at lower concentrations of Simvastatin and its efficacy was only verified at 156,25 µg.ml-1 or higher, what makes its use compromised, due to response of the animal cholesterol level. New antimycotic drugs must be developed and tested or even old drugs have to be investigated in order to avoid and report resistant species. Our test suggests that AgNP, once its toxicity is considered, should be used for treatment against dermatophyte mycosis.

Eixo Temático
  • MICROBIOLOGIA MÉDICA
Palavras-chave
SILVER NANOPARTICLE
SIMVASTATIN
FLUCONAZOLE
DERMATOPHYTES
MIC